公开(公告)号：US20120072069A1

公开(公告)日：2012-03-22

申请号：US13235655

申请日：2011-09-19

申请人： Hiroki INOUE ,  Yuichi Ochiai ,  Tomohiro Kani ,  Ichiro Usami ,  Takashi Wada

发明人： Hiroki INOUE ,  Yuichi Ochiai ,  Tomohiro Kani ,  Ichiro Usami ,  Takashi Wada

IPC分类号： G06F7/00

CPC分类号： B60R25/00

摘要： A communication system for a vehicle includes: a plurality of controllers mounted on the vehicle; a data communication network for coupling the plurality of controllers with each other so that the controllers transmit data to and receive data from each other via the data communication network; a failure diagnosis device for diagnosing whether each controller is normal; a failure diagnosis activation device for activating the failure diagnosis device; and an avoiding condition setting device for setting an avoiding condition, which provides to avoid execution of the failure diagnosis when the failure diagnosis device is activated.

摘要翻译： 车辆通信系统包括：安装在车辆上的多个控制器; 数据通信网络，用于将多个控制器彼此耦合，使得控制器经由数据通信网络将数据彼此传输和接收数据; 用于诊断每个控制器是否正常的故障诊断装置; 用于激活故障诊断装置的故障诊断激活装置; 以及用于设置避免条件的避免条件设置装置，其提供在故障诊断装置被激活时避免执行故障诊断。

公开(公告)号：US20070219210A1

公开(公告)日：2007-09-20

申请号：US10584632

申请日：2004-12-27

申请人： Naoaki Kanaya ,  Takashi Ishiyama ,  Ryo Muto ,  Yuichi Ochiai ,  Toshiyuki Watanabe ,  Noriko Shima

发明人： Naoaki Kanaya ,  Takashi Ishiyama ,  Ryo Muto ,  Yuichi Ochiai ,  Toshiyuki Watanabe ,  Noriko Shima

IPC分类号： A61K31/415 ,  A61K31/4427 ,  A61K31/497 ,  A61K31/501 ,  C07D231/04 ,  C07D401/14

CPC分类号： C07D401/14 ,  C07D401/04 ,  C07D403/04 ,  C07D403/14 ,  C07D405/14 ,  C07D417/14

摘要： A platelet coagulation inhibitor which inhibits neither COX-1 nor COX-2 is provided. The inhibitor is a compound represented by general formula (I): wherein Ar1 and Ar2 independently represent a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents, or a phenyl group optionally substituted with 1 to 3 substituents; R1 represents a lower acyl group, carboxyl group, a lower alkoxy carbonyl group, a lower alkoxy group, a lower alkyl group optionally substituted with 1 or 2 substituents, a carbamoyl group optionally substituted with 1 or 2 substituents, an oxamoyl group optionally substituted with 1 or 2 substituents, an amino group optionally substituted with 1 or 2 substituents, a 4- to 7-membered alicyclic heterocyclic group optionally substituted with 1 or 2 substituents, a phenyl group optionally substituted with 1 to 3 substituents, or a 5- or 6-membered aromatic heterocyclic group optionally substituted with 1 to 3 substituents; and R2 represents hydrogen atom, a halogeno group, or the like.

摘要翻译： 提供了既不抑制COX-1也不抑制COX-2的血小板凝血抑制剂。 抑制剂是由通式（I）表示的化合物：其中Ar 1和Ar 2独立地表示任选被1至 3个取代基或任选被1至3个取代基取代的苯基; R 1表示低级酰基，羧基，低级烷氧基羰基，低级烷氧基，任选被1或2个取代基取代的低级烷基，任选被1或2个取代基取代的氨基甲酰基，任选被 1或2个取代基，任选被1或2个取代基取代的氨基，任选被1或2个取代基取代的4-至7-元脂环族杂环基，任选被1至3个取代基取代的苯基，或5-或 任选被1至3个取代基取代的6元芳族杂环基; R 2表示氢原子，卤代基等。

公开(公告)号：US08729095B2

公开(公告)日：2014-05-20

申请号：US13393018

申请日：2010-08-27

申请人： Tatsuya Nishi ,  Masashi Hasegawa ,  Yumi Nakamoto ,  Yuichi Ochiai ,  Ryoko Kitazawa ,  Hiroshi Susaki

发明人： Tatsuya Nishi ,  Masashi Hasegawa ,  Yumi Nakamoto ,  Yuichi Ochiai ,  Ryoko Kitazawa ,  Hiroshi Susaki

IPC分类号： A61K31/44

CPC分类号： C07D413/04 ,  C07D401/04 ,  C07D471/04 ,  C07D498/04 ,  C07D513/04

摘要： A compound of the general formula (I): [wherein, R1 represents a halogen atom, or the like, R2 represents a hydrogen atom, or the like, R3 and R4, each independently, represent a hydrogen atom, a C1-4 alkyl group, or the like, R5 represents a hydrogen atom, a halogen atom, or the like, R6 represents a hydrogen atom, a halogen atom, or the like, R7 and R8, each independently, represent a hydrogen atom, a halogen atom, or the like, R9 and R10, each independently, represent a hydrogen atom, a C1-4 alkyl group, R11 and R12, each independently, represent a hydrogen atom, a C1-4 alkyl group, or the like, X represents an oxygen atom, a group —CH2—, or the like, Y represents a nitrogen atom, a group ═CH—, or the like, and Z represents a nitrogen atom, or the like] or a pharmacologically acceptable salt thereof, which has an excellent suppressive action on platelet aggregation, and is useful for prevention and/or treatment of thromboembolism.

摘要翻译： 通式（I）的化合物：[其中，R 1表示卤素原子等，R 2表示氢原子等，R 3和R 4各自独立地表示氢原子，C 1-4烷基 基团等，R 5表示氢原子，卤素原子等，R 6表示氢原子，卤素原子等，R 7和R 8各自独立地表示氢原子，卤素原子， R 9和R 10各自独立地表示氢原子，C 1-4烷基，R 11和R 12各自独立地表示氢原子，C 1-4烷基等，X表示氧 原子，基团-CH 2 - 等，Y表示氮原子，基团-CH-等，Z表示氮原子等]或其药理学上可接受的盐，其具有优异的 对血小板聚集的抑制作用，并且可用于预防和/或治疗血栓栓塞。

公开(公告)号：US08423242B2

公开(公告)日：2013-04-16

申请号：US13386176

申请日：2010-06-30

申请人： Yuichi Ochiai ,  Takamitsu Suzuki

发明人： Yuichi Ochiai ,  Takamitsu Suzuki

IPC分类号： G06F7/00

CPC分类号： G06F1/3203 ,  G06F1/3287 ,  H04W52/0254 ,  Y02D10/171 ,  Y02D50/20 ,  Y02D70/164 ,  Y02D70/20

摘要： In a vehicle equipped with a plurality of electronic devices, a power-saving system (100) saves electricity while comprehensively controlling the power supply status to each of the plurality of electronic devices. The power-saving system (100) includes: power supply status control portion (11) controlling the power supply status to each of the plurality of electronic devices depending on a usage situation of the vehicle; and usage situation determination portion (10) determining the usage situation on the basis of information useful for determining a usage situation, including information related to a usage date and time, current location or driver of the vehicle. The power supply status control portion (11) controls the power supply status to each of the plurality of electronic devices on the basis of a predetermined power supply status to each of the plurality of electronic devices set depending on a usage situation and the usage situation determined by the usage situation determination portion (10).

摘要翻译： 在配备有多个电子设备的车辆中，省电系统（100）在对多个电子设备中的每一个进行全面控制供电状态的同时节省电力。 省电系统（100）包括：电源状态控制部（11），其根据车辆的使用情况来控制多个电子设备中的每一个的供电状态; 以及使用状况判定部（10），其基于用于确定使用情况的信息，包括与使用日期和时间有关的信息，车辆的当前位置或驾驶员来确定使用情况。 电源状态控制部（11）根据使用情况而设定的多个电子设备中的每一个，根据所确定的使用情况，基于规定的电力供给状态来控制多个电子设备中的每一个的供电状态 通过使用情况判定部（10）。

公开(公告)号：US07622471B2

公开(公告)日：2009-11-24

申请号：US10543915

申请日：2004-02-06

申请人： Naoaki Kanaya ,  Hiroaki Ishihara ,  Youichi Kimura ,  Takashi Ishiyama ,  Yuichi Ochiai

发明人： Naoaki Kanaya ,  Hiroaki Ishihara ,  Youichi Kimura ,  Takashi Ishiyama ,  Yuichi Ochiai

IPC分类号： A61K31/497 ,  C07D237/00 ,  C07D237/02

CPC分类号： A61K31/551 ,  A61K31/4439 ,  A61K31/4545 ,  A61K31/496 ,  A61K31/501 ,  A61K31/5377 ,  A61K31/541 ,  C07D231/14 ,  C07D401/04 ,  C07D401/14 ,  C07D403/04 ,  C07D413/14 ,  C07D493/04

摘要： The present invention is directed to a strong platelet aggregation-inhibiting agent which does not inhibit COX-1 or COX-2. Further, the present invention provides compounds represented by formula (I), salts of the compounds, and solvates or hydrates of the compounds or the salts. Also provided are medicaments containing any of the compounds, salts, or solvates and preventive and/or therapeutic agents for ischemic diseases, containing any of the compounds, salts, or the solvates or hydrates.

摘要翻译： 本发明涉及不抑制COX-1或COX-2的强烈的血小板聚集抑制剂。 此外，本发明提供由式（I）表示的化合物，化合物的盐，化合物或其盐的溶剂合物或水合物。 还提供了含有任何化合物，盐或溶剂化物的药物，以及含有任何化合物，盐或溶剂合物或水合物的缺血性疾病的预防和/或治疗剂。

公开(公告)号：US20080064682A1

公开(公告)日：2008-03-13

申请号：US11571387

申请日：2005-07-01

申请人： Naoaki Kanaya ,  Takashi Ishiyama ,  Ryo Muto ,  Toshiyuki Watanabe ,  Yuichi Ochiai

发明人： Naoaki Kanaya ,  Takashi Ishiyama ,  Ryo Muto ,  Toshiyuki Watanabe ,  Yuichi Ochiai

IPC分类号： A61K31/55 ,  A61K31/415 ,  A61K31/44 ,  A61P9/00 ,  C07D231/02 ,  C07D401/00 ,  C07D413/00 ,  C07D243/08 ,  C07D211/68 ,  A61K31/445 ,  A61K31/5375

CPC分类号： C07D401/14 ,  C07D417/14

摘要： A compound represented by formula (I): (wherein Ar1 represents a phenyl group which may have 1 to 3 substituents, or a non-substituted 5- or 6-membered aromatic heterocyclic group; Ar2 represents (i) a non-substituted phenyl group, (ii) a phenyl group which has been substituted by a lower alkyl group having 1 to 3 groups or atoms selected from among a carbamoyl group, an amino group, a hydroxyl group, a lower alkoxy group, and a halogen atom, or (iii) a 5- or 6-membered nitrogen-containing aromatic heterocyclic group which has been substituted by 1 to 3 groups or atoms selected from among a lower alkyl group, a lower alkynyl group, a lower alkanoyl group, a carbamoyl group, a cyano group, an amino group, a hydroxyl group, a lower alkoxy group, and a halogen atom; and X represents a group represented by formula (II): (wherein the ring structure represents a 4- to 7-membered heterocyclic group which may have, in addition to the nitrogen atom shown in formula (II), one heteroatom selected from among nitrogen, oxygen, a sulfur, and which may be substituted by 1 to 4 groups or atoms selected from among a lower alkyl group, a carbamoyl group, an amino group, a hydroxyl group, a lower alkoxy group, an oxo group a lower alkanoyl group, a lower alkylsulfonyl group, and a halogen atom)), a salt thereof, a solvate of the compound or the salt, and a drug.

摘要翻译： 由式（I）表示的化合物：其中Ar 1表示可具有1至3个取代基的苯基或未取代的5或6元芳族杂环基团; Ar _{2 表示（i）未取代的苯基，（ii）被具有1〜3个选自氨基甲酰基，氨基， 羟基，低级烷氧基和卤素原子，或（iii）被1〜3个选自低级烷基，低级烷氧基， 低级炔基，低级烷酰基，氨基甲酰基，氰基，氨基，羟基，低级烷氧基和卤素原子; X表示由式（II）表示的基团：（其中 环结构表示除了式（II）所示的氮原子之外还可以具有o至4个的7-元杂环基 选自氮，氧，硫的杂原子，可以被1〜4个选自低级烷基，氨基甲酰基，氨基，羟基，低级烷氧基， 氧代基，低级烷酰基，低级烷基磺酰基和卤原子）），其盐，化合物或其盐的溶剂化物和药物。}

公开(公告)号：US07076871B2

公开(公告)日：2006-07-18

申请号：US10351544

申请日：2003-01-27

申请人： Kazunaga Horiuchi ,  Masaaki Shimizu ,  Nobuyuki Aoki ,  Yuichi Ochiai

发明人： Kazunaga Horiuchi ,  Masaaki Shimizu ,  Nobuyuki Aoki ,  Yuichi Ochiai

IPC分类号： H01R43/00

CPC分类号： H01L51/105 ,  B82Y10/00 ,  H01L51/0021 ,  H01L51/0048 ,  Y10S977/869 ,  Y10S977/873 ,  Y10T29/4902 ,  Y10T29/49099 ,  Y10T29/49117 ,  Y10T29/49174

摘要： A method of manufacturing a carbon nanotube device including an inner electrode, having connecting step, connecting a carbon nanotube to the inner electrode, wherein the connecting step comprises: attaching a conductor to an end or periphery thereof of a needle-shaped or rod-shaped carrying electrode; arranging the carbon nanotube in contact or close to a predetermined connection part of the inner electrode; approaching the end of the carrying electrode on which the conductor is carried to the connection part; and transferring the conductor carried on the carrying electrode to the connection part or periphery thereof to connect the carbon nanotube to the inner electrode.

摘要翻译： 一种制造碳纳米管装置的方法，其包括具有连接步骤的内部电极，将碳纳米管连接到所述内部电极，其中所述连接步骤包括：将导体附接到针状或棒状的端部或周边 承载电极; 将碳纳米管布置成与内部电极的预定连接部分接触或接近; 接近承载电极的端部，导体承载在其上的连接部分; 并且将承载在承载电极上的导体转移到其连接部分或周边以将碳纳米管连接到内部电极。

公开(公告)号：US20060123628A1

公开(公告)日：2006-06-15

申请号：US10351544

申请日：2003-01-27

申请人： Kazunaga Horiuchi ,  Masaaki Shimizu ,  Nobuyuki Aoki ,  Yuichi Ochiai

发明人： Kazunaga Horiuchi ,  Masaaki Shimizu ,  Nobuyuki Aoki ,  Yuichi Ochiai

IPC分类号： H01R43/00

CPC分类号： H01L51/105 ,  B82Y10/00 ,  H01L51/0021 ,  H01L51/0048 ,  Y10S977/869 ,  Y10S977/873 ,  Y10T29/4902 ,  Y10T29/49099 ,  Y10T29/49117 ,  Y10T29/49174

摘要： A method of manufacturing a carbon nanotube device including an inner electrode, having connecting step, connecting a carbon nanotube to the inner electrode, wherein the connecting step comprises: attaching a conductor to an end or periphery thereof of a needle-shaped or rod-shaped carrying electrode; arranging the carbon nanotube in contact or close to a predetermined connection part of the inner electrode; approaching the end of the carrying electrode on which the conductor is carried to the connection part; and transferring the conductor carried on the carrying electrode to the connection part or periphery thereof to connect the carbon nanotube to the inner electrode. A carbon nanotube device manufactured by this method includes a conductive particle which electrically connects the inner electrode and the carbon nanotube. Also disclosed is a carbon nanotube device having at least an inner electrode and a carbon nanotube electrically connected thereto, including a conductive particle that electrically connects the inner electrode to the carbon nanotube therethrough.

摘要翻译： 一种制造碳纳米管装置的方法，其包括具有连接步骤的内部电极，将碳纳米管连接到所述内部电极，其中所述连接步骤包括：将导体附接到针状或棒状的端部或周边 承载电极; 将碳纳米管布置成与内部电极的预定连接部分接触或接近; 接近承载电极的端部，导体承载在其上的连接部分; 并且将承载在承载电极上的导体转移到其连接部分或周边以将碳纳米管连接到内部电极。 通过该方法制造的碳纳米管装置包括将内部电极和碳纳米管电连接的导电性粒子。 还公开了至少具有与其电连接的内部电极和碳纳米管的碳纳米管装置，其包括将内部电极与碳纳米管电连接的导电性粒子。

公开(公告)号：US08722711B2

公开(公告)日：2014-05-13

申请号：US13879076

申请日：2011-10-13

申请人： Shigeo Yamanoi ,  Takahiro Katagiri ,  Hidenori Namiki ,  Madoka Hatta ,  Koji Matsumoto ,  Kanako Takahashi ,  Tomomi Yoshitomi ,  Yuichi Ochiai

发明人： Shigeo Yamanoi ,  Takahiro Katagiri ,  Hidenori Namiki ,  Madoka Hatta ,  Koji Matsumoto ,  Kanako Takahashi ,  Tomomi Yoshitomi ,  Yuichi Ochiai

IPC分类号： A61K31/4245 ,  C07D271/06

CPC分类号： C07D271/06 ,  A61K31/4245

摘要： Provided are compounds having an excellent hypoglycemic action and a β cell- or pancreas-protecting action or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause an increase in the blood sugar level due to abnormal sugar metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.

摘要翻译： 提供具有优异的降血糖作用和重要的化合物 细胞或胰腺保护作用或其药学上可接受的盐，以及对1型糖尿病，2型糖尿病等具有优异的治疗效果和/或预防效果的药物组合物，其导致血糖水平升高 由于糖代谢异常。 公开了由通式（I）表示的化合物或其药学上可接受的盐。

公开(公告)号：US08600608B2

公开(公告)日：2013-12-03

申请号：US13235655

申请日：2011-09-19

申请人： Hiroki Inoue ,  Yuichi Ochiai ,  Tomohiro Kani ,  Ichiro Usami ,  Takashi Wada

发明人： Hiroki Inoue ,  Yuichi Ochiai ,  Tomohiro Kani ,  Ichiro Usami ,  Takashi Wada

IPC分类号： G06F7/00

CPC分类号： B60R25/00

摘要： A communication system for a vehicle includes: a plurality of controllers mounted on the vehicle; a data communication network for coupling the plurality of controllers with each other so that the controllers transmit data to and receive data from each other via the data communication network; a failure diagnosis device for diagnosing whether each controller is normal; a failure diagnosis activation device for activating the failure diagnosis device; and an avoiding condition setting device for setting an avoiding condition, which provides to avoid execution of the failure diagnosis when the failure diagnosis device is activated.

摘要翻译： 车辆通信系统包括：安装在车辆上的多个控制器; 数据通信网络，用于将多个控制器彼此耦合，使得控制器经由数据通信网络将数据彼此传输和接收数据; 用于诊断每个控制器是否正常的故障诊断装置; 用于激活故障诊断装置的故障诊断激活装置; 以及用于设置避免条件的避免条件设置装置，其提供在故障诊断装置被激活时避免执行故障诊断。